Amyloid Precursor Protein Cleavage-Dependent and -Independent Axonal Degeneration Programs Share a Common Nicotinamide Mononucleotide Adenylyltransferase 1-Sensitive Pathway

Axonal degeneration is a hallmark of many debilitating neurological disorders and is thought to be regulated by mechanisms distinct from those governing cell body death. Recently, caspase 6 activation via amyloid precursor protein (APP) cleavage and activation of DR6 was discovered to induce axon degeneration after NGF withdrawal. We tested whether this pathway is involved in axonal degeneration caused by withdrawal of other trophic support, axotomy or vincristine exposure. Neurturin deprivation, like NGF withdrawal activated this APP/DR6/caspase 6 pathway and resulted in axonal degeneration, however, APP cleavage and caspase 6 activation were not involved in axonal degeneration induced by mechanical or toxic insults. However, loss of surface APP (sAPP) and caspase 6 activation were observed during axonal degeneration induced by dynactin 1(Dctn1) dysfunction, which disrupts axonal transport. Mutations in Dctn1 are associated with motor neuron disease and frontal temporal dementia, thus suggesting that the APP/caspase 6 pathway could be important in specific types of disease-associated axonal degeneration. The NGF deprivation paradigm, with its defined molecular pathway, was used to examine the context of Nmnat-mediated axonal protection. We found that although Nmnat blocks axonal degeneration after trophic factor withdrawal, it did not prevent loss of axon sAPP or caspase 6 activation within the axon, suggesting it acts downstream of caspase 6. These results indicate that diverse insults induce axonal degeneration via multiple pathways and that these degeneration signals converge on a common, Nmnat-sensitive program that is uniquely involved in axonal, but not cell body, degeneration.

[1]  A. Yaron,et al.  Axonal Degeneration Is Regulated by the Apoptotic Machinery or a NAD+-Sensitive Pathway in Insects and Mammals , 2010, The Journal of Neuroscience.

[2]  R. Kalb,et al.  A Switch in Retrograde Signaling from Survival to Stress in Rapid-Onset Neurodegeneration , 2009, The Journal of Neuroscience.

[3]  Li-Huei Tsai,et al.  Bridging Physiology and Pathology in AD , 2009, Cell.

[4]  D W Dickson,et al.  Characterization of DCTN1 genetic variability in neurodegeneration , 2009, Neurology.

[5]  J. Milbrandt,et al.  Transgenic Mice Expressing the Nmnat1 Protein Manifest Robust Delay in Axonal Degeneration In Vivo , 2009, The Journal of Neuroscience.

[6]  T. Araki,et al.  Nicotinamide Mononucleotide Adenylyltransferase Expression in Mitochondrial Matrix Delays Wallerian Degeneration , 2009, The Journal of Neuroscience.

[7]  K. Lund,et al.  A retrograde apoptotic signal originating in NGF-deprived distal axons of rat sympathetic neurons in compartmented cultures , 2009, Cell Research.

[8]  J. Milbrandt,et al.  Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide , 2009, The Journal of Neuroscience.

[9]  J. Milbrandt,et al.  A dual leucine kinase–dependent axon self-destruction program promotes Wallerian degeneration , 2009, Nature Neuroscience.

[10]  Y. Matsuoka,et al.  Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury , 2009, Nature Medicine.

[11]  C. Wiedemann Development and disease: Alzheimer's protein in embryonic pruning , 2009, Nature Reviews Neuroscience.

[12]  Marc Tessier-Lavigne,et al.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases , 2009, Nature.

[13]  M. Farrer,et al.  DCTN1 mutations in Perry syndrome , 2009, Nature Genetics.

[14]  A. Grierson,et al.  Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.

[15]  D. Price,et al.  Motor Neuron Disease Occurring in a Mutant Dynactin Mouse Model Is Characterized by Defects in Vesicular Trafficking , 2008, The Journal of Neuroscience.

[16]  B. Cui,et al.  A Functional Dynein–Microtubule Network Is Required for NGF Signaling Through the Rap1/MAPK Pathway , 2007, Traffic.

[17]  E. Holzbaur,et al.  Axonal transport and neurodegenerative disease. , 2006, Biochimica et biophysica acta.

[18]  J. Milbrandt,et al.  Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration after Axotomy , 2006, The Journal of Neuroscience.

[19]  L. Raymond,et al.  Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin , 2006, Cell.

[20]  Y. Sadovsky,et al.  N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury* , 2006, Journal of Biological Chemistry.

[21]  S. Reske,et al.  Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD , 2005, Annals of neurology.

[22]  M. Coleman Axon degeneration mechanisms: commonality amid diversity , 2005, Nature Reviews Neuroscience.

[23]  L. Luo,et al.  Axon retraction and degeneration in development and disease. , 2005, Annual review of neuroscience.

[24]  M. Saleh,et al.  Axonal Dynactin p150Glued Transports Caspase-8 to Drive Retrograde Olfactory Receptor Neuron Apoptosis , 2005, The Journal of Neuroscience.

[25]  K. Fischbeck,et al.  Distal spinal and bulbar muscular atrophy caused by dynactin mutation , 2005, Annals of neurology.

[26]  T. Laessig,et al.  Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal Apoptosis , 2004, The Journal of Neuroscience.

[27]  A. Ludolph,et al.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.

[28]  J. Milbrandt,et al.  Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration , 2004, Science.

[29]  S. Albrecht,et al.  Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. , 2004, The American journal of pathology.

[30]  Luquan Wang,et al.  A Web-based design center for vector-based siRNA and siRNA cassette , 2004, Bioinform..

[31]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[32]  W. Mobley,et al.  NGF Signaling in Sensory Neurons Evidence that Early Endosomes Carry NGF Retrograde Signals , 2003, Neuron.

[33]  Liqun Luo,et al.  Axon Pruning during Drosophila Metamorphosis Evidence for Local Degeneration and Requirement of the Ubiquitin-Proteasome System , 2003, Neuron.

[34]  J. Sanes,et al.  Inhibiting Axon Degeneration and Synapse Loss Attenuates Apoptosis and Disease Progression in a Mouse Model of Motoneuron Disease , 2003, Current Biology.

[35]  Shin J. Oh,et al.  Mutant dynactin in motor neuron disease , 2003, Nature Genetics.

[36]  I. Vernos,et al.  Dynactin is required for bidirectional organelle transport , 2003, The Journal of cell biology.

[37]  M. Raff,et al.  The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration , 2003, Cell Death and Differentiation.

[38]  D. Howland,et al.  Disruption of Dynein/Dynactin Inhibits Axonal Transport in Motor Neurons Causing Late-Onset Progressive Degeneration , 2002, Neuron.

[39]  Mart Saarma,et al.  The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.

[40]  V. Perry,et al.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene , 2001, Nature Neuroscience.

[41]  K. Moulder,et al.  Induction of BIM, a Proapoptotic BH3-Only BCL-2 Family Member, Is Critical for Neuronal Apoptosis , 2001, Neuron.

[42]  V. Allan,et al.  Dynactin , 2000, Current Biology.

[43]  M. Raff,et al.  Evidence That Wallerian Degeneration and Localized Axon Degeneration Induced by Local Neurotrophin Deprivation Do Not Involve Caspases , 2000, The Journal of Neuroscience.

[44]  Hideki Enomoto,et al.  The GDNF family ligands and receptors — implications for neural development , 2000, Current Opinion in Neurobiology.

[45]  L. Klesse,et al.  Trks: Signal transduction and intracellular pathways , 1999, Microscopy research and technique.

[46]  H. Gao,et al.  [Neurturin: a relative of glial-cell-line-derived neurotrophic factor]. , 1998, Sheng li ke xue jin zhan [Progress in physiology].

[47]  M. Dubois‐Dauphin,et al.  Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  S. Korsmeyer,et al.  Role of BCL-2 in the survival and function of developing and mature sympathetic neurons , 1995, Neuron.

[49]  T. Deckwerth,et al.  Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). , 1994, Developmental biology.

[50]  Z. Wszolek,et al.  Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review. , 2008, Parkinsonism & related disorders.